Biorestorative Therapies Inc (BRTX)

Apr 26, 2025

BioRestorative Therapies (OTCMKTS:BRTXQ) Trading Down 2.3% – Here’s Why - Defense World

Apr 26, 2025

Apr 23, 2025

Leveraging Stem Cells To Fight Chronic Lower Back Pain And Obesity With BioRestorative Therapies - The Globe and Mail

Apr 23, 2025

Apr 23, 2025

EQS-News: Leveraging Stem Cells To Fight Chronic Lower Back Pain And Obesity With BioRestorative Therapies - markets.businessinsider.com

Apr 23, 2025

Apr 16, 2025

BioRestorative Therapies Receives FDA Fast Track Approval For BRTX-100 To Treat Chronic Lumbar Disc Disease - FinancialContent

Apr 16, 2025

Apr 15, 2025

BioRestorative to Participate in Benzinga All-Access Show Today to Discuss Recent Achievements of Key Clinical & Regulatory Milestones, and Highlight Commercial Opportunities - TradingView

Apr 15, 2025

Apr 15, 2025

BioRestorative CEO Reveals Latest Clinical Breakthroughs and Market Expansion Plans - Stock Titan

Apr 15, 2025

Apr 10, 2025

BioRestorative unaffected by new U.S. tariffs, continues clinical trials - Investing.com South Africa

Apr 10, 2025

Apr 10, 2025

BioRestorative confirms no material impact from reciprocal tariffs - marketscreener.com

Apr 10, 2025

Apr 10, 2025

BioRestorative Confirms No Material Impact from Reciprocal Tariffs; All BRTX-100 Production & Manufacturing Performed in the United States - Yahoo

Apr 10, 2025

Apr 04, 2025

BioRestorative Therapies (OTCMKTS:BRTXQ) Shares Up 3.9% – Time to Buy? - Defense World

Apr 04, 2025

Apr 01, 2025

BioRestorative Therapies Reports Strong Growth Amid Challenges - MSN

Apr 01, 2025

Mar 31, 2025

Equities Analysts Issue Forecasts for BRTX FY2029 Earnings - Defense World

Mar 31, 2025

Mar 29, 2025

BioRestorative Therapies, Inc. (NASDAQ:BRTX) Q4 2024 Earnings Call Transcript - MSN

Mar 29, 2025

Mar 28, 2025

Earnings call transcript: BioRestorative’s Q4 2024 sees revenue growth, stock dip - Investing.com India

Mar 28, 2025

Mar 28, 2025

BioRestorative Therapies (BRTX) Projected to Post Earnings on Friday - Defense World

Mar 28, 2025

Mar 28, 2025

BioRestorative Therapies Reports Financial Gains and Clinical Progress - TipRanks

Mar 28, 2025

Mar 27, 2025

BioRestorative Therapies Reports 2024 Financial Results and Provides Business Update - TradingView

Mar 27, 2025

Mar 27, 2025

175% Revenue Surge: BioRestorative's Breakthrough Year With FDA Fast Track Success - Stock Titan

Mar 27, 2025

Mar 26, 2025

Earnings Preview For BioRestorative Therapies - Benzinga

Mar 26, 2025

Mar 25, 2025

BIORESTORATIVE THERAPIES Earnings Preview: Recent $BRTX Insider Trading, Hedge Fund Activity, and More - Nasdaq

Mar 25, 2025

Mar 25, 2025

BioRestorative Therapies Inc expected to post a loss of 28 cents a shareEarnings Preview - TradingView

Mar 25, 2025

Mar 25, 2025

BioRestorative Therapies (BRTX) Projected to Post Earnings on Thursday - Defense World

Mar 25, 2025

Mar 20, 2025

BioRestorative Therapies to Report 2024 Financial Results and Host Conference Call on March 27, 2025 - The Manila Times

Mar 20, 2025

Mar 20, 2025

BioRestorative Therapies, Inc. Scheduled to Release 2024 Financial Results on March 27, 2025 - Nasdaq

Mar 20, 2025

Mar 20, 2025

Clinical-Stage Stem Cell Leader BioRestorative Therapies Reveals 2024 Financial Results Date - Stock Titan

Mar 20, 2025

Mar 18, 2025

Stoke Therapeutics, Inc. (STOK) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance

Mar 18, 2025

Mar 16, 2025

Revolutionary: Stem Cell Therapy Puts Creative Medical on Profit Track - GeeksULTD

Mar 16, 2025

Mar 16, 2025

Revolutionary Breakthrough: BioRestorative Therapies Turns Profit! - GeeksULTD

Mar 16, 2025

Mar 12, 2025

BioRestorative Therapies (NASDAQ:BRTX) Trading 3.6% Higher – Should You Buy? - Defense World

Mar 12, 2025

Mar 11, 2025

Will BioRestorative's Cell Therapy Revolutionize The Spine Treatment Forte? - RTTNews

Mar 11, 2025

Mar 10, 2025

Reviewing Eastgate Biotech (OTCMKTS:ETBI) and BioRestorative Therapies (OTCMKTS:BRTX) - The AM Reporter

Mar 10, 2025

Feb 27, 2025

BioRestorative Therapies Says FDA Clears BRTX-100 Trial in Chronic Cervical Discogenic Pain - Marketscreener.com

Feb 27, 2025

Feb 27, 2025

BioRestorative Announces FDA Clearance of IND for Phase 2 Trial of BRTX-100 in Chronic Cervical Discogenic Pain - The Manila Times

Feb 27, 2025

Feb 27, 2025

BioRestorative announces FDA clearance of IND for Phase 2 BRTX-100 trial - TipRanks

Feb 27, 2025

Feb 26, 2025

BioRestorative Announces Updated Time for February 27th Webcasted Conference Call to Discuss Clinical Pipeline Update - Yahoo Finance

Feb 26, 2025

Feb 26, 2025

What Will BioRestorative Reveal About Its Stem Cell Therapies on February 27? - StockTitan

Feb 26, 2025

Feb 25, 2025

BioRestorative to Provide a Positive FDA Update on Clinical Pipeline - The Manila Times

Feb 25, 2025

Feb 25, 2025

FDA Green Light? BioRestorative Teases Major Clinical Breakthrough for Stem Cell Therapies - Stock Titan

Feb 25, 2025

Feb 23, 2025

Head to Head Review: BioRestorative Therapies (NASDAQ:BRTX) and Quipt Home Medical (NASDAQ:QIPT) - The AM Reporter

Feb 23, 2025

Feb 21, 2025

Comparing Quipt Home Medical (NASDAQ:QIPT) & BioRestorative Therapies (NASDAQ:BRTX) - Defense World

Feb 21, 2025

Feb 20, 2025

BioRestorative Receives FDA Fast Track Designation for BRTX-100 Chronic Lumbar Disc Disease Program - GlobeNewswire

Feb 20, 2025

Feb 20, 2025

Can This FDA-Fast-Tracked Therapy Finally Solve Chronic Back Pain? Phase 2 Data Shows Promise - StockTitan

Feb 20, 2025